221 related articles for article (PubMed ID: 18202786)
1. Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
Mukawa K; Fujii S; Tominaga K; Yoshitake N; Abe A; Kono T; Sekikawa A; Fukui H; Ichikawa K; Tomita S; Imura J; Ono Y; Shinoda M; Hiraishi H; Fujimori T
Oncol Rep; 2008 Feb; 19(2):393-9. PubMed ID: 18202786
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats.
Takeda J; Kitajima K; Fujii S; Horiuchi H; Hori H; Chibana Y; Okuyama T; Tominaga K; Ichikawa K; Ono Y; Teramoto T; Ohkura Y; Imura J; Shinoda M; Chiba T; Sakamoto C; Kawamata H; Fujimori T
Oncol Rep; 2004 May; 11(5):981-5. PubMed ID: 15069535
[TBL] [Abstract][Full Text] [Related]
3. Effects of nimesulide, a cyclooxygenase-2 selective inhibitor, on colitis induced tumors.
Inoue T; Hirata I; Murano M
Inflammopharmacology; 2008 Feb; 16(1):36-9. PubMed ID: 18256803
[TBL] [Abstract][Full Text] [Related]
4. R-etodolac induces E-cadherin and suppresses colitis-related mouse colon tumorigenesis.
Inoue T; Murano M; Yoda Y; Kuramoto T; Kakimoto K; Ishida K; Kawakami K; Abe Y; Morita E; Murano N; Tokioka S; Maemura K; Umegaki E; Higuchi K
Oncol Rep; 2010 Dec; 24(6):1487-92. PubMed ID: 21042743
[TBL] [Abstract][Full Text] [Related]
5. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions.
Clapper ML; Cooper HS; Chang WC
Acta Pharmacol Sin; 2007 Sep; 28(9):1450-9. PubMed ID: 17723178
[TBL] [Abstract][Full Text] [Related]
6. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice.
Liu ES; Ye YN; Shin VY; Yuen ST; Leung SY; Wong BC; Cho CH
Carcinogenesis; 2003 Aug; 24(8):1407-13. PubMed ID: 12807736
[TBL] [Abstract][Full Text] [Related]
8. Development of colonic neoplasms and expressions of p53 and p21 proteins in experimental colitis of mice induced by dextran sulfate sodium.
Takesue F; Korenaga D; Yao T; Kabashima A; Sugimachi K
J Exp Clin Cancer Res; 2001 Sep; 20(3):413-8. PubMed ID: 11718223
[TBL] [Abstract][Full Text] [Related]
9. A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model.
Fichera A; Little N; Dougherty U; Mustafi R; Cerda S; Li YC; Delgado J; Arora A; Campbell LK; Joseph L; Hart J; Noffsinger A; Bissonnette M
J Surg Res; 2007 Oct; 142(2):239-45. PubMed ID: 17574271
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of nimesulide on colorectal carcinogenesis in experimental murine ulcerative colitis.
Inoue T; Murano M; Abe Y; Morita E; Murano N; Yasumoto S; Toshina K; Nishikawa T; Maemura K; Hirata I; Katsu K
J Gastroenterol Hepatol; 2007 Sep; 22(9):1474-81. PubMed ID: 17716351
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium.
Chang WC; Coudry RA; Clapper ML; Zhang X; Williams KL; Spittle CS; Li T; Cooper HS
Carcinogenesis; 2007 Nov; 28(11):2375-81. PubMed ID: 17557903
[TBL] [Abstract][Full Text] [Related]
12. Effect of processed Scutellaria baicalensis on dextran sulfate sodium-induced colitis in mice.
Choi YA; Kang OH; Park HJ; Tae J; Kim DK; Kang CS; Choi SC; Yun KJ; Choi SJ; Nah YH; Kim YH; Bae KH; Lee YM
Int J Mol Med; 2005 Oct; 16(4):667-72. PubMed ID: 16142402
[TBL] [Abstract][Full Text] [Related]
13. Impaired antioxidant defense system of colonic tissue and cancer development in dextran sulfate sodium-induced colitis in mice.
Korenaga D; Takesue F; Kido K; Yasuda M; Inutsuka S; Honda M; Nagahama S
J Surg Res; 2002 Feb; 102(2):144-9. PubMed ID: 11796011
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
Cooper HS; Murthy SN; Shah RS; Sedergran DJ
Lab Invest; 1993 Aug; 69(2):238-49. PubMed ID: 8350599
[TBL] [Abstract][Full Text] [Related]
15. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice.
Martín AR; Villegas I; Alarcón de la Lastra C
Inflamm Res; 2005 Apr; 54(4):145-51. PubMed ID: 15883736
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention for colorectal tumorigenesis associated with chronic colitis in mice via apoptosis.
Orii S; Yamaguchi T; Anzai H; Saito S; Chiba T; Suzuki K
J Exp Clin Cancer Res; 2003 Mar; 22(1):41-6. PubMed ID: 12725321
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor, etodolac.
Yamamoto K; Kitayama W; Denda A; Sasahira T; Kuniyasu H; Kirita T
Pathobiology; 2006; 73(6):317-24. PubMed ID: 17374970
[TBL] [Abstract][Full Text] [Related]
18. Effect of DSS-induced colitis on visceral sensitivity to colorectal distension in mice.
Larsson MH; Rapp L; Lindström E
Neurogastroenterol Motil; 2006 Feb; 18(2):144-52. PubMed ID: 16420293
[TBL] [Abstract][Full Text] [Related]
19. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.
Fujii S; Fujimori T; Kawamata H; Takeda J; Kitajima K; Omotehara F; Kaihara T; Kusaka T; Ichikawa K; Ohkura Y; Ono Y; Imura J; Yamaoka S; Sakamoto C; Ueda Y; Chiba T
Gut; 2004 May; 53(5):710-6. PubMed ID: 15082590
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of a new anti-inflammatory agent, IS-741, on dextran sulfate sodium-induced experimental colitis in rats.
Makino J; Andoh A; Hata K; Yotsuya S; Shikama H; Araki Y; Fujiyama Y; Bamba T
Int J Mol Med; 2002 Apr; 9(4):391-6. PubMed ID: 11891534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
